Month: <span>May 2017</span>

Home / 2017 / May
Post

Researchers uncover potential risks of common MS treatment

In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug. The study aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting multiple sclerosis by analyzing health records of over 2,000 British Columbians with multiple sclerosis between 1995 and 2008. “Once a...

Post

A dual-functional GLP-1 analogue may improve insulin sensitivity and help fight diabetes

According to research published online in The FASEB Journal, scientists have discovered a dual peptide called “PGLP-1” that promotes insulin secretion and inhibits gluconeogenesis (a metabolic process that produces glucose). A related compound called GLP-1 is currently used in diabetes treatments. This new compound shows the potential to improve glycemic control for patients with type 1...

Post

Could painful knee replacements be a thing of the past? Scientists may have uncovered arthritis cure

Researchers have found a molecule protects against cartilage deterioration   Injecting high levels of the molecule in rats prevented arthritis’ development  Molecule replacement therapy could take the place of artificial joint procedures  Joint replacements have a long healing process and carry risks of complications Scientists may be one step closer to finding a cure for...

Post

Keyhole knee surgery for arthritis pain ‘is pointless’: Warning minor procedure has been oversold as a cure for all problems

British Medical Journal report warns that benefits of surgery have been oversold  Study found it was no better at treating pain than conservative management More than 150,000 Britons undergo the keyhole operation every year Keyhole knee operations on patients with a common form of arthritis should stop as they do little to help, researchers warn...

Post

Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs

Highlights Stem cells were rewired via genome engineering to combat inflammation Cells were used to engineer tissues that self-regulate biologic drug production Autoregulated therapy protected tissues from cytokines that drive chronic diseases This approach can form the basis of a cellular vaccine for inflammatory diseases Summary Chronic inflammatory diseases such as arthritis are characterized by...

Post

Researchers ID drug that blocks some blood cancers

  A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS. Their research, published May 15 in the Journal of Clinical Investigation, also demonstrates that the compound deters multiple myeloma, another type of blood malignancy. Few effective treatments are available for primary effusion lymphoma(PEL), a subtype...

Post

Diabetes drug may help symptoms of autism associated condition

Metformin 500mg tablets.  A widely used diabetes medication could help people with a common inherited form of autism, research shows. Scientists found that a drug called metformin improves sociability and reduces symptomatic behaviours in adult mice with a form of Fragile X syndrome. Researchers say that metformin could be repurposed as a therapy for Fragile X syndrome...

Post

Rodents with trouble walking reveal potential treatment approach for most common joint disease

Maintaining the supply of a molecule that helps to nourish cartilage prevented osteoarthritis in animal models of the disease, according to a report published in Nature Communications online May 11. The study is the first, say its authors, to provide evidence that adenosine, a biochemical at the heart of human cellular function, plays another crucial role—keeping on hand...